Stock listing
NASDAQ:ICPT Intercept Pharmaceuticals Inc Stock
Follow Intercept Pharmaceuticals Inc into a list and get an email when it puts out news.
Last close · NASDAQ:ICPT
$19.00 USD
Close on Nov 14, 2023 · No longer trades
- Lowest – highest close
- $9.17 – $462.26 USDSince Oct 11, 2012 · lowest May 24, 2023 · highest Mar 14, 2014
Delisted NASDAQ:ICPT no longer trades. Its last trading date is unknown. Company history and updates stay available on this page.
- Ticker
- NASDAQ:ICPT
- Asset type
- Stock
- Exchange
- NASDAQ
- Currency
- USD
Intercept Pharmaceuticals Inc on 6ix
- Calls
- 10 calls with a replay · 10 with a transcript · latest Aug 2, 2023
- Decks
- 3 decks · latest Jan 11, 2023
Events
| Call | When | Status |
|---|---|---|
| Intercept Pharmaceuticals (ICPT) Q2 2023 Earnings Call | Wed, Aug 02, 2023 · 8:30 AM ET | Replay |
| Intercept Pharmaceuticals (ICPT) Q1 2023 Earnings Call | Thu, Apr 27, 2023 · 8:00 AM ET | Replay |
| Intercept Pharmaceuticals (ICPT) Q4 2022 Earnings Call | Thu, Mar 02, 2023 · 8:30 AM ET | Replay |
| Intercept Pharmaceuticals (ICPT) Q3 2022 Earnings Call | Tue, Nov 01, 2022 · 8:30 AM ET | Replay |
| Intercept Pharmaceuticals (ICPT) Q2 2022 Earnings Call | Wed, Aug 03, 2022 · 8:30 AM ET | Replay |
| Intercept Pharmaceuticals (ICPT) Q1 2022 Earnings Call | Fri, May 06, 2022 · 8:30 AM ET | Replay |
| Intercept Pharmaceuticals (ICPT) Q4 2021 Earnings Call | Wed, Mar 02, 2022 · 8:30 AM ET | Replay |
| Intercept Pharmaceuticals (ICPT) Q3 2021 Earnings Call | Wed, Nov 03, 2021 · 8:30 AM ET | Replay |
| Intercept Pharmaceuticals (ICPT) Q2 2021 Earnings Call | Thu, Jul 29, 2021 · 8:30 AM ET | Replay |
| Intercept Pharmaceuticals (ICPT) Q1 2021 Earnings Call | Thu, May 06, 2021 · 8:30 AM ET | Replay |
Decks
| Deck | Kind | Slides | Date |
|---|---|---|---|
| J.P. Morgan Healthcare Conference 2023 | Conference | 23 slides | Jan 11, 2023 |
| Technical Presentation (July 2022) | Technical | 9 slides | Jul 7, 2022 |
| Investor Day (December 2015) | Investor day | 92 slides | Dec 1, 2015 |
People
6ix reads each seat by machine from the page it links to, and can misread one.
| Person | Seat |
|---|---|
| Srinivas Akkaraju Other companies: Kalaris Therapeutics, Inc. (Director · Since at least Mar 18, 2025); Alumis Inc. (Founder and Managing Member, Samsara BioCapital · Since at least Jun 27, 2024); vTv Therapeutics Inc. (Director · Since at least Feb 23, 2024); Mineralys Therapeutics, Inc. (Board Member · Since at least Feb 9, 2023); Scholar Rock Holding Corporation (Director · Since at least Jul 26, 2022); Jiya Acquisition Corp (Director · Sep 23, 2022 – Sep 23, 2022 · Past); Syros Pharmaceuticals, Inc. (Director · Jun 1, 2022 – Sep 16, 2024 · Past); Aduro Biotech Inc (Director · May 26, 2022 – Aug 11, 2023 · Past) | Director · May 25, 2022 – Nov 8, 2023 · Past |
| Gino Santini Other companies: COMPASS Pathways Plc (CHAIRMAN OF THE BOARD · Since at least Sep 3, 2024); Collegium Pharmaceutical, Inc. (Chairman of the Board · Since at least Sep 10, 2015); Allena Pharmaceuticals Inc (Director · Nov 1, 2017 – Jun 3, 2021 · Past); Vitae Pharmaceuticals Inc (Director · May 26, 2016 – Oct 25, 2016 · Past); AMAG Pharmaceuticals Inc (Director · May 19, 2016 – Nov 16, 2020 · Past); Horizon Pharma PLC (Director · May 3, 2016 – May 3, 2018 · Past) | Director · Nov 24, 2015 – Nov 8, 2023 · Past |
| Keith Gottesdiener Other companies: Septerna, Inc. (Director · Since at least Sep 25, 2025); Prime Medicine, Inc. (See Remarks, Director · Oct 19, 2022 – May 8, 2025 · Past); Rhythm Pharmaceuticals, Inc. (CEO & President, Director · Oct 4, 2017 – Mar 9, 2020 · Past) | Director · Jul 19, 2016 – Nov 8, 2023 · Past |
| Nancy Miller-Rich Other companies: 4D Molecular Therapeutics, Inc. (Director · Since at least Dec 10, 2020); Aldeyra Therapeutics, Inc. (Director · Since at least Jan 13, 2020); Kadmon Holdings Inc (Director · Aug 13, 2020 – Nov 9, 2021 · Past) | Director · Apr 24, 2018 – Nov 8, 2023 · Past |
| Bryan Ball Other companies: Whitehawk Therapeutics, Inc. (Chief Technical Operations Officer · Since at least Apr 23, 2024); Immunomedics Inc (Chief Quality Officer · Mar 5, 2019 – Oct 23, 2020 · Past) | Chief Qual. Officer & SVP Ops. · Jan 11, 2021 – Jul 11, 2022 · Past |
| Gail Cawkwell Other companies: Aclaris Therapeutics, Inc. (Chief Medical Officer · Jun 27, 2022 – Jul 1, 2023 · Past) | SVP, Med Affairs, Safety & PV · Dec 4, 2018 – Feb 12, 2022 · Past |
| Lisa Bright Other companies: Ascendis Pharma A/S (Board Member · Since at least Mar 18, 2026) | President, International · Apr 1, 2019 – Jul 1, 2020 · Past |
| Lisa DeFrancesco Other companies: Lexicon Pharmaceuticals, Inc. (Senior Vice President, Investor Relations and Corporate Communications · Since at least Oct 2, 2024) | SVP, IR & Corp. Affairs · Feb 15, 2021 – Dec 31, 2021 · Past |
| Mark Pruzanski Other companies: Equillium, Inc. (Director · Since at least Oct 11, 2018) | Director · Apr 9, 2013 – Nov 8, 2023 · Past |
| Nicole Williams Other companies: Progenics Pharmaceuticals Inc (Director · Jun 8, 2016 – Jul 11, 2019 · Past) | Director · Jul 20, 2015 – Nov 20, 2015 · Past |
All 14 people
| Person | Seat |
|---|---|
| Rachel McMinn Other companies: Neurogene Inc. (Founder and Chief Executive Officer · Since at least Dec 18, 2023) | Chief Strategy Officer · Apr 30, 2014 – Oct 2, 2017 · Past |
| Richard J Kim Other companies: Avadel Pharmaceuticals PLC (Chief Commercial Officer · Feb 15, 2021 – Feb 20, 2024 · Past) | President US Comm & Strat Mktg · May 1, 2017 – Dec 31, 2020 · Past |
| Luciano Adorini | See Remarks · Apr 9, 2013 – Feb 1, 2016 · Past |
| M Michelle Berrey | President, R&D and CMO · Nov 8, 2023 – Nov 8, 2023 · Past |
Log in to ask 6ix AI your own questions about Intercept Pharmaceuticals Inc.